Overall Rank
Rank in SubField 1
Publications
Total Cites
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2,096 out of 176,292 Researchers
Data For The Year: 2026
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 124,294 | 131,895 |
| Total Cites | 2,721 | 2,986 |
| H-index | 22 | 23 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 39 | 39 |
| Total Cites to Single+First Authored Papers | 33 | 34 |
| Number of Single+First+Last Authored Papers | 77 | 77 |
| Total Cites to Single+First+Last Authored Papers | 87 | 91 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,748 | 1,838 |
| Ratio of Total Citations to Distinct Citing Papers | 1.56 | 1.62 |
| Self-Citation Percentage |
8.87%
|
|
Overall Rank
Rank in SubField 1
Publications
Total Cites
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,677 out of 166,615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 91,171 | 96,389 |
| Total Cites | 2,782 | 3,087 |
| H-index | 22 | 23 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 38 | 38 |
| Total Cites to Single+First Authored Papers | 54 | 57 |
| Number of Single+First+Last Authored Papers | 71 | 71 |
| Total Cites to Single+First+Last Authored Papers | 109 | 118 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,760 | 1,865 |
| Ratio of Total Citations to Distinct Citing Papers | 1.58 | 1.66 |
| Self-Citation Percentage |
9.88%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.